Triple Negative Breast Cancer: Halaven plus Keytruda
About the two study drugs in Triple Negative Breast Cancer Both study drugs are FDA approved. Halaven is approved for advanced breast cancer and Keytruda
Glioblastoma: Epilepsy drug plus standard treatment
Background about Glioblastoma Glioblastoma, GBM, is an aggressive and the most frequent malignant brain tumor primary brain tumor with poor prognosis. At diagnosis, the standard
Lung cancer and thyroid – First RET+ drug, Retevmo
The FDA has approved Retevmo capsules for the treatment of patients with lung cancer or thyroid cancer harboring RET alterations. This is the first therapy
Kidney Cancer – Opdivo plus Cabometyx prolong life
Background Patients with advanced or metastatic kidney cancer are a population that despite recent advances remains in need of additional therapeutic options that extend survival.
Compassionate Drugs – What are they?
“Compassionate drugs“, also called “named patient drugs” or “early access drugs”. Compassionate drugs can be one of three cases: Compassionate drugs (1) – Can be
Chondrosarcoma – Ivosidenib works in Chondrosarcoma
Chondrosarcoma and IDH1 – Background For locally advanced and/or metastatic Chondrosarcoma, no known effective therapy exists. The standard protocols are not effective. Mutations in the
GBM that disappeared from Monica’s MRI from 4.3.20
Monica (not her real name), a 43-year-old Cyprus resident, was diagnosed with GBM brain cancer, Glioblastoma, two years ago. One year ago Monica’s husband contacted
Triple Negative Breast Cancer and Stunning Biological Drug, IMMU-132
FDA may approve new biological drug called IMMU-132 for treating patients with triple negative breast cancer On a personal note “My mother died of triple-negative
A combination with a new biological drug, Navicixizumab, Shows Benefit in Ovarian Cancer
New Trial – Ovarian Cancer Data from the phase Ib study were made available as part of the virtual platform for the SGO 2020 Annual Meeting
Corona Virus and Cancer
What is the link between the corona virus and cancer? The world is experiencing an outbreak of a new betacoronavirus known as Severe Acute Respiratory
FDA Grants Breakthrough Therapy Designation to JNJ-6372 in mNSCLC
Published on March 10, 2020 Background The FDA granted Breakthrough Therapy designation to JNJ-61186372 (JNJ-6372) for the treatment of patients with Metastatic Non-Small Cell Lung
Does genetic test extends the lives of Pancreatic Cancer patients?
Currently, it does not seem so and so one should think and think again about doing them especially for their high cost. Published on March
